Corbus Pharmaceuticals (CRBP) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free CRBP Stock Alerts $44.13 -2.47 (-5.30%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Corbus Pharmaceuticals Stock Price Performance5 Day Performance-6.15%1 Month Performance+2.65%3 Month Performance-1.78%6 Month Performance+727.95%Year-To-Date Performance+630.63%1 Year Performance+405.50% Receive CRBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. CRBP Stock Chart for Monday, June, 10, 2024 CRBP Chart by TradingView Corbus Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$46.60$44.13-5.30%$46.05$42.10243,826 shs$471.62 million06/06/2024$47.02$46.60-0.89%$47.31$45.36219,584 shs$498.15 million06/05/2024$47.11$47.02-0.19%$49.00$46.12193,535 shs$502.64 million06/04/2024$46.83$47.11+0.60%$49.82$46.23279,111 shs$503.61 million06/03/2024$42.80$46.83+9.42%$50.48$43.41596,584 shs$500.61 million05/31/2024$41.50$42.80+3.13%$44.32$41.28166,849 shs$457.53 million Get the Latest News and Ratings for CRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$43.50$41.50-4.60%$45.45$41.50223,909 shs$443.64 million05/29/2024$42.69$43.50+1.90%$43.67$41.6493,451 shs$464.88 million05/28/2024$45.02$42.69-5.18%$46.25$41.60140,478 shs$456.36 million05/27/2024$45.02$45.02$45.53$40.36162,700 shs$481.26 million05/24/2024$41.38$45.02+8.80%$45.52$40.36162,709 shs$481.26 million05/23/2024$44.96$41.38-7.96%$45.87$40.68146,255 shs$442.35 million05/22/2024$45.20$44.96-0.53%$45.74$41.62148,001 shs$480.62 million05/21/2024$48.55$45.20-6.90%$50.42$44.58342,072 shs$483.19 million05/20/2024$45.00$48.55+7.89%$49.18$44.51301,234 shs$519.00 million05/17/2024$45.92$45.00-2.00%$46.22$43.63123,932 shs$481.05 million05/16/2024$44.14$45.92+4.03%$46.26$43.78124,176 shs$490.89 million05/15/2024$42.99$44.14+2.68%$46.00$43.51251,845 shs$471.86 million05/14/2024$42.87$42.99+0.28%$43.64$42.39106,440 shs$459.43 million05/13/2024$42.99$42.87-0.28%$44.80$41.67151,962 shs$458.28 million05/10/2024$43.74$42.99-1.71%$43.88$40.5192,122 shs$451.70 million05/09/2024$42.39$43.74+3.18%$43.81$42.34650,384 shs$459.58 million05/08/2024$39.77$42.39+6.59%$44.66$39.31779,160 shs$445.52 million05/07/2024$38.82$39.77+2.45%$40.34$37.91160,188 shs$417.98 million05/06/2024$38.77$38.82+0.13%$39.24$37.52108,035 shs$408.00 million05/03/2024$38.20$38.77+1.49%$39.23$37.41134,675 shs$407.47 million05/02/2024$37.25$38.20+2.55%$39.37$37.62140,840 shs$401.48 million05/01/2024$37.04$37.25+0.57%$38.58$36.60133,291 shs$391.50 million04/30/2024$35.64$37.04+3.93%$37.04$34.93197,470 shs$389.29 million04/29/2024$34.25$35.64+4.06%$36.24$34.4992,781 shs$374.47 million04/26/2024$33.50$34.25+2.24%$34.63$32.2796,874 shs$359.97 million04/25/2024$35.54$33.50-5.74%$35.09$32.03142,333 shs$352.09 million04/24/2024$37.74$35.54-5.83%$38.34$34.24220,992 shs$373.53 million04/23/2024$37.70$37.74+0.11%$40.08$37.66500,504 shs$396.65 million04/22/2024$39.24$37.70-3.92%$39.94$36.8294,727 shs$396.23 million04/19/2024$36.53$39.24+7.42%$39.86$35.79283,601 shs$412.41 million04/18/2024$37.16$36.53-1.70%$37.78$35.26128,015 shs$383.93 million04/17/2024$41.12$37.16-9.63%$41.12$36.09419,840 shs$390.55 million04/16/2024$42.72$41.12-3.75%$45.00$40.96353,253 shs$432.17 million04/15/2024$40.85$42.72+4.58%$42.96$39.58347,486 shs$448.86 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.04/12/2024$40.00$40.85+2.13%$40.99$39.17291,720 shs$429.33 million04/11/2024$38.15$40.00+4.85%$40.15$37.00186,773 shs$420.28 million04/10/2024$37.47$38.15+1.81%$38.56$35.5065,900 shs$400.96 million04/09/2024$40.16$37.47-6.70%$40.89$36.01232,344 shs$393.81 million04/08/2024$39.97$40.16+0.48%$42.20$37.50208,997 shs$422.08 million04/05/2024$38.97$39.97+2.57%$40.35$38.81151,833 shs$420.09 million04/04/2024$38.50$38.97+1.22%$40.67$38.77161,340 shs$409.58 million04/03/2024$37.46$38.50+2.78%$40.29$37.01274,207 shs$404.64 million04/02/2024$37.99$37.46-1.40%$40.64$35.80270,881 shs$393.71 million04/01/2024$39.24$37.99-3.19%$40.94$37.99173,177 shs$399.28 million03/29/2024$39.24$39.24$40.00$35.16235,133 shs$412.41 million03/28/2024$35.57$39.24+10.32%$39.96$35.16234,957 shs$412.41 million03/27/2024$36.15$35.57-1.60%$36.53$33.24179,249 shs$373.84 million03/26/2024$35.63$36.15+1.46%$38.24$35.34239,802 shs$379.21 million03/25/2024$34.94$35.63+1.97%$36.56$35.00296,512 shs$373.76 million03/22/2024$38.15$34.94-8.41%$38.00$34.44187,536 shs$366.52 million03/21/2024$39.17$38.15-2.60%$39.46$37.26293,968 shs$400.19 million03/20/2024$42.76$39.17-8.40%$43.76$38.65275,150 shs$410.89 million03/19/2024$41.62$42.76+2.74%$43.86$39.50134,554 shs$448.55 million03/18/2024$43.68$41.62-4.72%$43.13$39.01328,120 shs$436.59 million03/15/2024$45.13$43.68-3.21%$46.74$42.28633,281 shs$458.20 million03/14/2024$47.08$45.13-4.14%$48.07$43.98296,127 shs$437.31 million03/13/2024$44.58$47.08+5.61%$49.87$45.15478,462 shs$456.21 million03/12/2024$38.28$44.58+16.46%$45.33$39.82595,987 shs$431.98 million03/11/2024$44.93$38.28-14.80%$43.49$37.01409,968 shs$370.93 million Related Companies: LTRN Stock Price Chart LPTX Stock Price Chart ORGS Stock Price Chart TNXP Stock Price Chart ARVN Stock Price Chart ZLAB Stock Price Chart CPRX Stock Price Chart GLPG Stock Price Chart KROS Stock Price Chart EVO Stock Price Chart Receive CRBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRBP) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.